Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

A study using lab-made models of the brain suggests that a herpes virus may be a key link between concussions and dementia ...

A University of California, Irvine-led research team has discovered intricate molecular mechanisms driving the RNA processing ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...

First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer ... for later life memory and risk of dementia, according to a new study. The study compared the differences ...

A new study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate groups and proposed an explanation for how cognitive impairment arises. The ...

All 16 of Indiana’s designated senior care organizations — known as Area Agencies on Aging — are now required to have a ...